A 12-month randomized controlled trial evaluating erythritol air-polishing versus curette/ultrasonic debridement of mandibular furcations in supportive periodontal therapy

被引:16
|
作者
Ulvik, Ingvild M. [1 ]
Saethre, Terje [1 ]
Bunaes, Dagmar F. [1 ]
Lie, Stein Atle [1 ]
Enersen, Morten [2 ]
Leknes, Knut N. [1 ]
机构
[1] Univ Bergen, Dept Clin Dent, Fac Med, Aarstadveien 19, N-5009 Bergen, Norway
[2] Univ Oslo, Inst Oral Biol, Fac Dent, Oslo, Norway
关键词
Air-polishing; Erythritol; Furcation involvement; Periodontal maintenance; Visual analogue scale;
D O I
10.1186/s12903-021-01397-3
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background Due to complex morphology and limited access, the cleaning of the furcation area is extremely challenging. Therefore, novel therapeutic approaches need to be tested to potentially overcome debridement limitations. The aim of the present prospective 12-month study was to compare clinical and microbiological effects following erythritol air-polishing versus conventional mechanical debridement of furcation defects in a cohort of periodontal maintenance patients. Methods Twenty patients with grade II mandibular molar furcation defects volunteered to enroll in this single-centre, examiner masked, randomized controlled trial. In a split-mouth study design, two furcation sites in each patient were randomly assigned to either receive subgingival debridement using erythritol air-polishing (test) or conventional ultrasonic/curette debridement (control) at baseline, and at 3, 6, 9 and 12 months. Probing depth, clinical attachment level and bleeding on probing were recorded at 3-month intervals. Subgingival microbiological samples obtained at baseline, 6 and 12 months were analyzed using checkerboard DNA-DNA hybridization. Discomfort from treatment was scored at 12 months using a visual analogue scale. The differences between treatments, and time-points, were tested using multilevel analysis (mixed effect models and robust variance estimates). Results A significant reduction in probing depth took place following both treatments (p < 0.001). Control sites experienced a significant mean gain in clinical attachment level of 0.5 mm (0.2) (p=0.004), whereas a non-significant gain of 0.4 mm (0.3) was observed at test sites (p=0.119). At 6 months, a significant between-treatment difference of 0.8 mm (+/- 0.4) was observed in favor of the control (p=0.032). No significant between-treatment differences were observed in microbial load or composition. Notably, at 12 months patients experienced significantly less discomfort following air-polishing compared with control (p=0.001). Conclusions The 12-month observations indicate that erythritol air-polishing and conventional mechanical debridement both support clinical improvements. A significant between-treatment difference in clinical attachment level was, however, detected in favour of control debridement at 6 months. In terms of patient comfort, erythritol air-polishing is superior. Trial Registration: The clinical trial was retrospectively registered in ClinicalTrial.gov with registration NCT04493398 (07/28/2020).
引用
收藏
页数:11
相关论文
共 27 条
  • [21] Cognitive Therapy-as-Usual versus Cognitive Therapy plus the Memory Support Intervention for adults with depression: 12-month outcomes and opportunities for improved efficacy in a secondary analysis of a randomized controlled trial
    Zieve, Garret G.
    Sarfan, Laurel D.
    Dong, Lu
    Tiab, Sondra S.
    Tran, Melanie
    Harvey, Allison G.
    BEHAVIOUR RESEARCH AND THERAPY, 2023, 170
  • [22] Is the benefit of sequential 5-fluorouracil and daylight photodynamic therapy versus daylight photodynamic therapy alone sustained over time?-12-month follow-up of a randomized controlled trial
    Wiegell, Stine Regin
    Fredman, Gabriella
    Andersen, Flemming
    Bjerring, Peter
    Paasch, Uwe
    Haedersdal, Merete
    PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY, 2025, 51
  • [23] Periodontal regenerative therapy using recombinant human fibroblast growth factor (rhFGF)-2 in combination with carbonate apatite granules or rhFGF-2 alone: 12-month randomized controlled trial
    Imamura, Kentaro
    Yoshida, Wataru
    Seshima, Fumi
    Aoki, Hideto
    Yamashita, Keiko
    Kitamura, Yurie
    Murakami, Tasuku
    Ambiru, Mayuri
    Bizenjima, Takahiro
    Katayama, Akihiko
    Tomita, Sachiyo
    Saito, Atsushi
    CLINICAL ORAL INVESTIGATIONS, 2024, 28 (11)
  • [24] HIGH-INTENSITY FOCUSED ELECTROMAGNETIC THERAPY VERSUS PELVIC FLOOR THERAPY WITH BIOFEEDBACK FOR TREATMENT OF FEMALE URINARY INCONTINENCE. A MULTI-CENTER RANDOMIZED-CONTROLLED TRIAL: 12-MONTH ANALYSIS
    Guerette, Nathan L.
    LASERS IN SURGERY AND MEDICINE, 2022, 54 : S54 - S54
  • [25] Tele-transitions of care. A 12-month, parallel-group, superiority randomized controlled trial protocol, evaluating the use of telehealth versus standard transitions of care in the prevention of avoidable hospital readmissions
    Noel, Kimberly
    Yagudayev, Shamuel
    Messina, Catherine
    Schoenfeld, Elinor
    Hou, Wei
    Kelly, Gerald
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2018, 12 : 9 - 16
  • [26] Durability of treatment effects of the sleep position trainer versus oral appliance therapy in positional OSA: 12-month follow-up of a randomized controlled trial (vol 22, pg 441, 2017)
    de Ruiter, Maurits H. T.
    Benoist, Linda B. L.
    de Vries, Nico
    de Lange, Jan
    SLEEP AND BREATHING, 2018, 22 (02) : 451 - 451
  • [27] Extended antiplatelet therapy with clopidogrel alone versus clopidogrel plus aspirin after completion of 9-to 12-month dual antiplatelet therapy for acute coronary syndrome patients with both high bleeding and ischemic risk. Rationale and design of the OPT-BIRISK double-blinded, placebo-controlled randomized trial
    Li, Yi
    Jing, Quanmin
    Wang, Bing
    Wang, Xiaozeng
    Li, Jing
    Qiao, Shubing
    Chen, Shaoliang
    Angiolillo, Dominick J.
    Han, Yaling
    AMERICAN HEART JOURNAL, 2020, 228 : 1 - 7